Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:4.1.2.42 (
DTA
)
1,693
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Resistin is an adipocyte-secreted hormone proposed to link obesity with insulin resistance and diabetes, but no previous study has performed a joint quantitative evaluation of white adipose tissue (WAT)
resistin
mRNA expression and serum levels in relation to insulinemia and glycemia in mice. We have thus comparatively assessed WAT
resistin
mRNA expression and serum
resistin
levels in lean C57BL/6J mice and various mouse models of obesity, including diet-induced obese (DIO) C57BL/6J mice, high fat-fed TNF-alpha-/- mice, and brown adipose tissue (BAT)-deficient uncoupling protein-diphtheria toxin A chain (UCP1-
DTA
) mice. We also studied whether treatment with the weight-reducing and insulin-sensitizing compounds, MTII, an alpha-melanocyte-stimulating hormone analog, or CNTF(Ax15), a ciliary neurotrophic factor analog, alters
resistin
mRNA expression and/or circulating levels in lean and DIO C57BL/6J mice. We find that
resistin
mRNA expression is similar in DIO and lean C57BL/6J mice, as well as in TNF-alpha-/- and wild-type (WT) mice. Circulating
resistin
levels, however, are higher in DIO C57BL/6J, high fat-fed TNF-alpha-/-, and UCP1-
DTA
mice compared with lean controls. Moreover, although
resistin
mRNA expression is upregulated by MTII treatment for 24 h and downregulated by CNTF(Ax15) treatment for 3 or 7 days, circulating
resistin
levels are not altered by MTII or CNTF(Ax15) treatment. In addition, serum
resistin
levels, but not
resistin
mRNA expression levels, are correlated with body weight, and neither
resistin
mRNA expression nor serum
resistin
levels are correlated with serum insulin or glucose levels. We conclude that transcriptional regulation of
resistin
in WAT does not correlate with circulating
resistin
levels and that circulating
resistin
is unlikely to play a major endocrine role in insulin resistance or glycemia in mice.
...
PMID:Circulating resistin in lean, obese, and insulin-resistant mouse models: lack of association with insulinemia and glycemia. 1552 96